Search research articles
Contact Us
Filters
Showing results (231-240 of 292) with videos related to
Page
of 30
Sort By:
Nature
|
January 31, 2025
Author Correction: Stromal changes in the aged lung induce an emergence from melanoma dormancy
Mitchell E Fane, Yash Chhabra, Gretchen M Alicea, et al.
Cancer Research
|
April 9, 2009
Genetic mutations associated with cigarette smoking in pancreatic cancer
Amanda Blackford, Giovanni Parmigiani, Thomas W Kensler, et al.
Cell Reports
|
November 17, 2021
Evaluating the impact of age on immune checkpoint therapy biomarkers
Rossin Erbe, Zheyu Wang, Sharon Wu, et al.
Cancer Immunology Research
|
January 12, 2026
Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses
Dimitri N Sidiropoulos, Zhehao Zhang, Jennifer N Durham, et al.
Oncotarget
|
June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Katherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2017
Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy
Avani D Rao, Yufei Liu, Rie von Eyben, et al.
Oncoimmunology
|
August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
Katherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
Cell
|
September 7, 2024
Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy
Yash Chhabra, Mitchell E Fane, Sneha Pramod, et al.
JCI Insight
|
August 6, 2024
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma
Nicole E Gross, Zhehao Zhang, Jacob T Mitchell, et al.
Nature Communications
|
June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial
Hejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Page
of 30
Search research articles
Search
Showing results (231-240 of 292) with videos related to
Sort By:
Page
of 30
Nature
|
January 31, 2025
Author Correction: Stromal changes in the aged lung induce an emergence from melanoma dormancy
Mitchell E Fane, Yash Chhabra, Gretchen M Alicea, et al.
Cancer Research
|
April 9, 2009
Genetic mutations associated with cigarette smoking in pancreatic cancer
Amanda Blackford, Giovanni Parmigiani, Thomas W Kensler, et al.
Cell Reports
|
November 17, 2021
Evaluating the impact of age on immune checkpoint therapy biomarkers
Rossin Erbe, Zheyu Wang, Sharon Wu, et al.
Cancer Immunology Research
|
January 12, 2026
Cytometric Atlas of Combination Immunotherapy in Pancreatic Cancer: Blood-Based Signatures Reveal Vaccine and Checkpoint Inhibitor Responses
Dimitri N Sidiropoulos, Zhehao Zhang, Jennifer N Durham, et al.
Oncotarget
|
June 12, 2020
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Katherine M Bever, Erkut H Borazanci, Elizabeth A Thompson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 22, 2017
Multiplex Proximity Ligation Assay to Identify Potential Prognostic Biomarkers for Improved Survival in Locally Advanced Pancreatic Cancer Patients Treated With Stereotactic Body Radiation Therapy
Avani D Rao, Yufei Liu, Rie von Eyben, et al.
Oncoimmunology
|
August 15, 2025
A phase 2 trial of CXCR4 antagonism and PD1 inhibition in metastatic pancreatic adenocarcinoma reveals recruitment of T cells but also immunosuppressive macrophages
Katherine M Bever, Sarah M Shin, Jennifer N Durham, et al.
Cell
|
September 7, 2024
Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy
Yash Chhabra, Mitchell E Fane, Sneha Pramod, et al.
JCI Insight
|
August 6, 2024
Phosphodiesterase-5 inhibition collaborates with vaccine-based immunotherapy to reprogram myeloid cells in pancreatic ductal adenocarcinoma
Nicole E Gross, Zhehao Zhang, Jacob T Mitchell, et al.
Nature Communications
|
June 23, 2026
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial
Hejia Henry Wang, Amanda L Huff, S Daniel Haldar, et al.
Page
of 30